Value of Irish executive's shares in Jazz pharma soars to $150m

Seamus Mulligan has seen the value of his shares in Jazz Pharmaceuticals soar to around €150 million, after the firm's share price hit a high of almost $60.

6th October, 2012
Value of Irish executive's shares in Jazz pharma soars to $150m
Seamus Mulligan: owns 3.3 million shares in Jazz. Photo: Tony O'Shea

Irish pharma executive Seamus Mulligan has seen the value of his shares in Jazz Pharmaceuticals soar to around €150 million, after the Nasdaq-listed firm's share price hit a high of almost $60.

Mulligan, who owns 3.3 million shares in Jazz, co-founded Azur Pharma in 2005. Azur completed a $500 million merger with Jazz in January, and Mulligan currently owns around 5.75 per cent of the merged entity.

Shares in Jazz have risen over the past few weeks after its victory...

Subscribe from just €1 for the first month!

Currency

What's Included

With any subscription you will have access to

  • 971569B3-2C5E-4C45-B798-CEADE16987A8

    Unlimited multi-device access to our iPad, iPhone and Android Apps

  • 099C8662-C57C-42F2-9426-F2F90DF17C8F

    Unlimited access to our eReader library

  • 198AE43B-B9CF-4892-8769-D63C2104BA08

    Exclusive daily insight and opinion seven days a week

  • D8F37B78-25E4-4E4A-A376-4F5789B1564A

    Create alerts to never miss a subject that matters to you

  • B15F2521-37CD-4E02-B898-730A20D39F7F

    Get access to exclusive offers for subscribers on gifts and experiences

  • A564FE02-1AB8-4579-AF9D-BA32A2E5ACA7

    Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine

Share this post

Related Stories

The year in review

Legacy Richie Oakley 1 year ago

Newsround: What Thursday’s papers say

Legacy Leanna Byrne 5 years ago

More cycle routes, expansion of Luas to Bray and new bus network proposed

Legacy Digital Desk 5 years ago